Cite
Wu YD, Yang KZ, Zhou DN, et al. Clinical observation of (125)I-labeled anti-alpha fetoprotein antibody radioimmunotherapy in hepatocellular carcinoma. World J Gastroenterol. 1997;3(1):43-6doi: 10.3748/wjg.v3.i1.43.
Wu, Y. D., Yang, K. Z., Zhou, D. N., Gang, Y. Q., Song, X. Q., Hu, X. H., & Huang, B. Y. (1997). Clinical observation of (125)I-labeled anti-alpha fetoprotein antibody radioimmunotherapy in hepatocellular carcinoma. World journal of gastroenterology, 3(1), 43-6. https://doi.org/10.3748/wjg.v3.i1.43
Wu, Y D, et al. "Clinical observation of (125)I-labeled anti-alpha fetoprotein antibody radioimmunotherapy in hepatocellular carcinoma." World journal of gastroenterology vol. 3,1 (1997): 43-6. doi: https://doi.org/10.3748/wjg.v3.i1.43
Wu YD, Yang KZ, Zhou DN, Gang YQ, Song XQ, Hu XH, Huang BY. Clinical observation of (125)I-labeled anti-alpha fetoprotein antibody radioimmunotherapy in hepatocellular carcinoma. World J Gastroenterol. 1997 Mar 15;3(1):43-6. doi: 10.3748/wjg.v3.i1.43. PMID: 27006585; PMCID: PMC4796838.
Copy
Download .nbib